DK3014279T3 - Fremgangsmåde til bestemmelse af proteinaggregater under anvendelse af overflade-fida - Google Patents
Fremgangsmåde til bestemmelse af proteinaggregater under anvendelse af overflade-fida Download PDFInfo
- Publication number
- DK3014279T3 DK3014279T3 DK14752793.1T DK14752793T DK3014279T3 DK 3014279 T3 DK3014279 T3 DK 3014279T3 DK 14752793 T DK14752793 T DK 14752793T DK 3014279 T3 DK3014279 T3 DK 3014279T3
- Authority
- DK
- Denmark
- Prior art keywords
- fida
- determination
- procedure
- protein aggregates
- aggregates
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
- G01N33/533—Production of labelled immunochemicals with fluorescent label
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/645—Specially adapted constructive features of fluorimeters
- G01N21/6456—Spatial resolved fluorescence measurements; Imaging
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/645—Specially adapted constructive features of fluorimeters
- G01N21/6456—Spatial resolved fluorescence measurements; Imaging
- G01N21/6458—Fluorescence microscopy
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4703—Regulators; Modulating activity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4709—Amyloid plaque core protein
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/924—Hydrolases (3) acting on glycosyl compounds (3.2)
- G01N2333/936—Hydrolases (3) acting on glycosyl compounds (3.2) acting on beta-1, 4 bonds between N-acetylmuramic acid and 2-acetyl-amino 2-deoxy-D-glucose, e.g. lysozyme
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/30—Psychoses; Psychiatry
- G01N2800/302—Schizophrenia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Rehabilitation Therapy (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102013106713.1A DE102013106713A1 (de) | 2013-06-26 | 2013-06-26 | Verfahren zur Ermittlung von Indikatoren zur Bestimmung von Krankheiten |
PCT/EP2014/063418 WO2014207049A2 (de) | 2013-06-26 | 2014-06-25 | Verfahren zur ermittlung von indikatoren zur bestimmung von krankheiten |
Publications (1)
Publication Number | Publication Date |
---|---|
DK3014279T3 true DK3014279T3 (da) | 2023-01-09 |
Family
ID=51359355
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK14752793.1T DK3014279T3 (da) | 2013-06-26 | 2014-06-25 | Fremgangsmåde til bestemmelse af proteinaggregater under anvendelse af overflade-fida |
Country Status (9)
Country | Link |
---|---|
US (1) | US11175288B2 (da) |
EP (3) | EP4180816A3 (da) |
JP (1) | JP6478987B2 (da) |
CN (1) | CN105358978A (da) |
DE (1) | DE102013106713A1 (da) |
DK (1) | DK3014279T3 (da) |
ES (1) | ES2935060T3 (da) |
FI (1) | FI3014279T3 (da) |
WO (1) | WO2014207049A2 (da) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102015003404B4 (de) * | 2015-03-18 | 2021-10-07 | Forschungszentrum Jülich GmbH | Verfahren zur Herstellung eines Standards für den Nachweis von Proteinaggregaten einer Proteinfehlfaltungserkrankung sowie Standard und dessen Verwendung |
DE102016121455A1 (de) * | 2016-11-09 | 2018-05-09 | Forschungszentrum Jülich GmbH | Ultrasensitiver Nachweis von Virus- und Virus-ähnlichen Partikeln |
US11142570B2 (en) | 2017-02-17 | 2021-10-12 | Bristol-Myers Squibb Company | Antibodies to alpha-synuclein and uses thereof |
JP2020509748A (ja) * | 2017-03-07 | 2020-04-02 | ユニバーシティ オブ ピッツバーグ −オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション | 神経変性疾患病理のオプトジェネティク誘発 |
JP6886854B2 (ja) * | 2017-04-13 | 2021-06-16 | シスメックス株式会社 | 被検物質の情報取得方法 |
DE102017010455A1 (de) * | 2017-06-13 | 2018-12-13 | Forschungszentrum Jülich GmbH | Verfahren zum Nachweis von Aggregaten biotherapeutischer Substanzen in einer Probe |
JP2020148598A (ja) * | 2019-03-13 | 2020-09-17 | 株式会社Jvcケンウッド | 分析用基板の作製方法 |
CN113518925A (zh) * | 2019-03-13 | 2021-10-19 | Jvc建伍株式会社 | 分析用基板的制作方法、分析用基板及分析单元 |
JP2020148599A (ja) * | 2019-03-13 | 2020-09-17 | 株式会社Jvcケンウッド | 分析用基板及び分析ユニット |
DE102020003794A1 (de) * | 2020-06-25 | 2021-12-30 | Forschungszentrum Jülich GmbH | Verfahren, Verwendung des Verfahrens sowle Kit zum Nachweis von Bioindikatoren in einer Probe |
CN113008850B (zh) * | 2021-02-07 | 2022-02-25 | 首都医科大学宣武医院 | 诊断阿尔茨海默病的用途及诊断阿尔茨海默病的装置 |
WO2024005008A1 (ja) * | 2022-06-28 | 2024-01-04 | 大塚製薬株式会社 | シヌクレイノパチーを判定するための方法 |
CN115266663B (zh) * | 2022-06-30 | 2023-06-16 | 四川省医学科学院·四川省人民医院 | 一种肠道微环境触发的非侵入式诊断帕金森病的生物探针及其制备方法和应用 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0884583A1 (en) * | 1997-06-10 | 1998-12-16 | Evotec BioSystems GmbH | A method for characterizing samples in at least two dimensional space of specific physical properties |
WO2005018424A2 (en) * | 2003-08-18 | 2005-03-03 | Research Foundation For Mental Hygiene, Inc. | Antibodies specific for fibrillar amyloid and a procedure to detect fibrillar amyloid deposits |
AU2005327652A1 (en) * | 2005-02-19 | 2006-08-24 | Peoplebio, Inc. | Method for differentially detecting multimeric form from monomeric form of multimer-forming polypeptides |
DE102005031429A1 (de) * | 2005-07-04 | 2007-01-11 | Heinrich-Heine-Universität Düsseldorf | Verfahren zur selektiven Bestimmung pathologischer Proteinablagerungen |
EP1987361A4 (en) * | 2006-01-30 | 2009-03-04 | Invitrogen Corp | COMPOSITIONS AND METHODS FOR DETECTING AND QUANTIFYING TOXIC SUBSTANCES IN DISEASE STATES |
DE102006010647A1 (de) * | 2006-03-06 | 2007-09-13 | Latza, Reinhard, Dr.med. | Test zum Nachweis von pathologischen Prionen |
WO2007126473A2 (en) | 2006-04-10 | 2007-11-08 | Oligomerix, Inc. | Oligomerization of amyloid proteins |
WO2008070229A2 (en) * | 2006-08-28 | 2008-06-12 | Case Western Reserve University | Detection of pathogenic aggregates of protein in a sample by homologous elisa |
WO2008140639A2 (en) * | 2007-02-08 | 2008-11-20 | Oligomerix, Inc. | Biomarkers and assays for alzheimer's disease |
DE202007003085U1 (de) | 2007-03-02 | 2007-05-24 | BSH Bosch und Siemens Hausgeräte GmbH | Laugenbehälter für eine Waschmaschine |
WO2010003227A1 (en) * | 2008-07-08 | 2010-01-14 | Amorfix Life Sciences Ltd. | Detection of protein aggregates |
KR20130043088A (ko) * | 2010-02-09 | 2013-04-29 | 브리스톨-마이어스 스큅 컴퍼니 | 면역검정 표준물 및 검정내 보정 표준물을 사용한 임상 바이오마커의 측정 |
DE102011057019A1 (de) * | 2011-12-23 | 2013-06-27 | Forschungszentrum Jülich GmbH | Standard zur Quantifizierung von pathogenen Aggregaten aus körpereigenen Proteinen |
DE102011057021A1 (de) | 2011-12-23 | 2013-06-27 | Forschungszentrum Jülich GmbH | Verfahren zur selektiven Quantifizierung von A-Beta-Aggregaten |
-
2013
- 2013-06-26 DE DE102013106713.1A patent/DE102013106713A1/de active Pending
-
2014
- 2014-06-25 EP EP22200832.8A patent/EP4180816A3/de not_active Withdrawn
- 2014-06-25 FI FIEP14752793.1T patent/FI3014279T3/de active
- 2014-06-25 ES ES14752793T patent/ES2935060T3/es active Active
- 2014-06-25 EP EP22200826.0A patent/EP4180815A3/de active Pending
- 2014-06-25 WO PCT/EP2014/063418 patent/WO2014207049A2/de active Application Filing
- 2014-06-25 EP EP14752793.1A patent/EP3014279B1/de active Active
- 2014-06-25 DK DK14752793.1T patent/DK3014279T3/da active
- 2014-06-25 JP JP2016522473A patent/JP6478987B2/ja not_active Expired - Fee Related
- 2014-06-25 CN CN201480036386.XA patent/CN105358978A/zh active Pending
- 2014-06-25 US US14/900,361 patent/US11175288B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
DE102013106713A1 (de) | 2014-12-31 |
EP4180815A3 (de) | 2023-11-01 |
JP6478987B2 (ja) | 2019-03-06 |
EP4180815A2 (de) | 2023-05-17 |
JP2016524151A (ja) | 2016-08-12 |
EP3014279A2 (de) | 2016-05-04 |
US20160161481A1 (en) | 2016-06-09 |
EP3014279B1 (de) | 2022-10-12 |
CN105358978A (zh) | 2016-02-24 |
WO2014207049A2 (de) | 2014-12-31 |
EP4180816A3 (de) | 2023-07-26 |
US11175288B2 (en) | 2021-11-16 |
WO2014207049A3 (de) | 2015-09-17 |
ES2935060T3 (es) | 2023-03-01 |
EP4180816A2 (de) | 2023-05-17 |
FI3014279T3 (en) | 2023-01-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3014279T3 (da) | Fremgangsmåde til bestemmelse af proteinaggregater under anvendelse af overflade-fida | |
DK3043816T3 (da) | Anti-b7-h1-antistoffer til behandling af tumorer | |
DK3192902T3 (da) | Fremgangsmåde til fremstilling af graphenholdige viscosefibre | |
DK3096741T3 (da) | Fremgangsmåde til fremstillingen af hybridosomer | |
DK3083540T3 (da) | Fremgangsmåde til fremstilling af substituerede phenoxyphenylketoner | |
DK3603794T3 (da) | Fremgangsmåde til overflader med gelmønster | |
DK3587448T3 (da) | Heterodimere proteiner | |
DK3556775T3 (da) | Anti-lag-3 antistoffer til behandling af hæmatologiske maligniteter | |
DK2996556T3 (da) | System til billedstyret procedure | |
DK3174858T3 (da) | Fremgangsmåde til fremstilling af pyrazoler | |
DK3336106T3 (da) | Anti-fcrh5-antistoffer | |
DK3072835T3 (da) | Fremgangsmåde til fremføring | |
DK2970954T3 (da) | Modifikation af polypeptider | |
DK3327123T3 (da) | Fremgangsmåder til sekvensering af immunrepertoiret | |
DK3010895T3 (da) | Fremgangsmåde til fremstilling af 4-propargyleret aminobenzoxazinoner | |
DK3708583T3 (da) | Ikke-fucosylerede anti-fgfr2iiib-antistoffer | |
DK3013544T3 (da) | Fremgangsmåde til betonfremstilling | |
DK3054976T3 (da) | Anvendelse af semaphorin-4d-bindende molekyler til behandling af aterosklerose | |
FI20135770A (fi) | Prosessi hiilivetyjen valmistamiseksi | |
DK3041857T3 (da) | Protein a-kromatografi | |
DK3050883T3 (da) | Fremgangsmåde til fremstilling af diazabicyclooctanderivater og mellemprodukter | |
DK2969098T3 (da) | Fremgangsmåder til oprensning af antistoffer | |
DK2992104T3 (da) | Fremgangsmåde til ekspression | |
DK3434760T3 (da) | Fremgangsmåder til forøgelse af mannose-indholdet i rekombinante proteiner | |
DK2970379T3 (da) | Fremgangsmåder til forhøjelse af proteinrenhed ved anvendelse af protein a-baseret kromatografi |